GenHealth and Ruitian Comprehensive Outpatient Department signed a strategic cooperation agreement

发布时间:

2025-06-11 15:52:27

GenHealth and Ruitian Comprehensive Outpatient Department signed a strategic cooperation agreement

On May 28, 2025, Shanghai - Jianhu Health and Ruitian Comprehensive Outpatient Department (hereinafter referred to as "Ruitian Outpatient") officially signed a strategic cooperation agreement. Both parties will integrate cutting-edge medical resources and technological advantages to provide full lifecycle health management solutions covering "prevention, intervention, treatment, and rehabilitation" for high net worth clients in Asia. Yankit Hui, Executive President of Jianhu Health, Lin Weiming, Co founder and Executive Director of Ruitian Clinic, and Co founder Li Tiancheng attended the signing ceremony together.

 


Left: Lin Weiming, co-founder and executive director of Ruitian Clinic; Chinese: Yankit Hui, Executive President of Jianhu Health; Right: Li Tiancheng, co-founder of Ruitian Clinic

 


Ruitian Clinic: the core carrier of the national level cell medicine transformation platform
Ruitian Clinic is located in the Guangci Sinan National Translational Medicine Innovation Industrial Park in Shanghai. The park is an international level biopharmaceutical research and development hub jointly built by the National Development and Reform Commission and the Shanghai Municipal Government, gathering cutting-edge medical technology clinical translation projects. As a benchmark institution in the park, Ruitian Clinic relies on the cell drug research and development system of Shanghai Xunyuan Biotechnology Co., Ltd. to build a "production research clinical" closed loop:

Research core: Shanghai Huangpu Ruitian Cell Therapy Research Institute, under its umbrella, was established with the approval of the Municipal Science and Technology Commission, led by Professor Zhang Chuansen (head of the preparatory group of the Chinese Stem Cell Association), focusing on the research and development of stem cell, immune cell, and extracellular vesicle technologies;

Clinical strength: equipped with GMP laboratory, postdoctoral workstation, and seven major clinical departments, providing regenerative medicine level treatment services; Full cycle management: Pioneering the "Private Doctor MDT Model", covering the entire chain of precision testing, health intervention, chronic disease treatment, and anti-aging management.

 
 

Strong alliance: integrating cutting-edge medical resources

This cooperation focuses on the field of health management for high net worth individuals, deeply integrating the core advantages of both parties:

 


As an innovative and professional medical institution, Ruitian Comprehensive Outpatient Department has always provided customers with full lifecycle health management services through the integration of functional medicine, traditional Chinese and Western medicine, and regenerative medicine intervention methods. It relies on the strong research and development capabilities of Shanghai Xunyuan Cell Biotechnology Co., Ltd., focusing on the research and application of stem cell, immune cell, and extracellular vesicle technologies. It is committed to comprehensive intervention from health and sub-health to chronic diseases and cancer postoperative care, and has built a complete disease prevention and treatment management system. In this cooperation, Ruitian Clinic will fully leverage its technological advantages in the field of regenerative medicine to provide more cutting-edge health management solutions for high net worth individuals.

 


GenHealth always adheres to the core concept of "prevention is better than treatment", deeply integrates Japanese precision medicine, Hong Kong international resources, and mainland tertiary hospital system, and builds a health management network covering core cities in Asia. Through an intelligent health monitoring system and a dedicated consultant team, we provide high net worth clients with one-stop services ranging from early cancer screening in Japan, high-end physical examinations in Hong Kong, to cellular anti-aging treatments, making top-notch medical resources truly accessible health protection for our clients. This cooperation with Ruitian Comprehensive Outpatient Department will introduce new technologies and concepts of regenerative medicine to Jianhu Health, further enriching the connotation and level of its health management services.

 


Left: Lin Weiming, co-founder and executive director of Ruitian Clinic; Center: Yankit Hui, CEO of Jianhu Health, signed a contract on-site